LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Buparlisib | 10 | uM | LJP5 | 72 | hr | 1235 | 506 | 4660 | 0.1083 | -0.3763 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 5018 | 4660 | 1.0771 | 1.0794 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4962 | 4660 | 1.0662 | 1.0687 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4822 | 4660 | 1.0368 | 1.0391 |
MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 5016 | 4660 | 1.0779 | 1.0809 |
MDA-MB-231 | XL147 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4806 | 4660 | 1.0325 | 1.0341 |
MDA-MB-231 | XL147 | 10 | uM | LJP5 | 72 | hr | 1235 | 4168 | 4660 | 0.8954 | 0.8881 |
MDA-MB-231 | Y39983 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3398 | 4405 | 0.7713 | 0.7357 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3402 | 4405 | 0.7729 | 0.7380 |
MDA-MB-231 | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3149 | 4405 | 0.7147 | 0.6648 |
MDA-MB-231 | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2999 | 4405 | 0.6805 | 0.6200 |
MDA-MB-231 | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2849 | 4405 | 0.6466 | 0.5757 |
MDA-MB-231 | Y39983 | 10 | uM | LJP6 | 72 | hr | 1235 | 403 | 4405 | 0.0917 | -0.4576 |
MDA-MB-231 | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4845 | 4405 | 1.1005 | 1.1078 |
MDA-MB-231 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4658 | 4405 | 1.0590 | 1.0642 |
MDA-MB-231 | Nintedanib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4411 | 4405 | 1.0009 | 1.0006 |
MDA-MB-231 | Nintedanib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4282 | 4405 | 0.9730 | 0.9709 |
MDA-MB-231 | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 4079 | 4405 | 0.9266 | 0.9190 |
MDA-MB-231 | Nintedanib | 10 | uM | LJP6 | 72 | hr | 1235 | 1099 | 4405 | 0.2479 | -0.0743 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4266 | 4660 | 0.9153 | 0.9094 |
MDA-MB-231 | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3081 | 4660 | 0.6608 | 0.6093 |
MDA-MB-231 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1389 | 4660 | 0.2979 | 0.0616 |
MDA-MB-231 | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1371 | 4660 | 0.2942 | 0.0542 |
MDA-MB-231 | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1122 | 4660 | 0.2411 | -0.0495 |
MDA-MB-231 | Foretinib | 10 | uM | LJP5 | 72 | hr | 1235 | 708 | 4660 | 0.1517 | -0.2539 |